NCT02598466View on ClinicalTrials.gov

Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept

Sponsors
All Listed Sponsors
collaborator

Hexor, South Africa

OTHER

lead

Bristol-Myers Squibb

INDUSTRY

NCT02598466 - Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa | Biotech Hunter | Biotech Hunter